Crossmark

Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction

Crossref DOI link: https://doi.org/10.1186/s13054-017-1870-3

Published Online: 2017-11-29

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Klingele, Matthias http://orcid.org/0000-0002-8592-4071
Stadler, Theresa

Fliser, Danilo

Speer, Timo

Groesdonk, Heinrich V.

Raddatz, Alexander
License Information

Text and Data Mining valid from 2017-11-29
More Information

Article History

Received: 24 July 2017

Accepted: 23 October 2017

First Online: 29 November 2017

Ethics approval and consent to participate

: Not applicable; see the Methods section of the main text.

: Not applicable; see the Methods section of the main text.

: MK received speaker fees from Baxter, Fresenius Medical Care and Cytosorbents, DF received honoraria from Fresenius Medical Care. The other authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.